Back to search

Article

Safety and biodistribution of Nanoligomers <sup>™</sup> targeting SARS-CoV-2 genome for treatment of COVID-19

2022-07-20

Abstract excerpt

As the world braces to enter its third year in the coronavirus disease 2019 (COVID-19) pandemic, the need for accessible and effective antiviral therapeutics continues to be felt globally. The recent surge of Omicron variant cases has demonstrated that vaccination and prevention alone cannot quell the spread of highly transmissible variants. A safe and nontoxic therapeutic with an adaptable design to respond to th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a1e5c212-651b-54ee-9292-e576c7b63fbb
DOI
10.1101/2022.07.19.500688
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Safety and biodistribution of Nanoligomers <sup>™</sup> targeting SARS-CoV-2 genome for treatment of COVID-19DOI 10.1101/2022.07.19.500688
An intranasal ASO therapeutic targeting SARS-CoV-2Semantic proximity
A potent synthetic nanobody targets RBD and protects mice from SARS-CoV-2 infectionSemantic proximity
A vimentin-targeting oral compound with host-directed antiviral and anti-inflammatory actions addresses multiple features of COVID-19 and related diseasesSemantic proximity
A broadly neutralizing biparatopic Nanobody protects mice from lethal challenge with SARS-CoV-2 variants of concernSemantic proximity
Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeuticsSemantic proximity
A potent neutralizing nanobody against SARS-CoV-2 with inhaled delivery potentialSemantic proximity
Next‐Generation Vaccines: Nanovaccines in the Fight against SARS‐CoV‐2 Virus and beyond SARS‐CoV‐2Semantic proximity
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics.Semantic proximity
Lung-selective Cas13d-based nanotherapy inhibits lethal SARS-CoV-2 infection by targeting host protease <i>Ctsl</i>Semantic proximity
Anti-COVID-19 Activity of FDA Approved Drugs through RNA G-quadruplex BindingSemantic proximity
Antisense oligonucleotide: A promising therapeutic option to beat COVID ‐19Semantic proximity
A potent synthetic nanobody targets RBD and protects mice from SARS-CoV-2 infectionSemantic proximity
Select a neighboring publication to make it the new centre.